11月21日 - ** 远程医疗公司 Doximity < DOCS.N (link) > 股价上涨 8.8%，报 50.47 美元
** Raymond James 将其评级从 "跑赢大盘 "上调至 "强力买入"，目标价为 65 美元。
** 券商认为，人工智能货币化和医疗服务提供商可能转向直接面向消费者的模式具有潜力，可支持高于市场水平的增长。
** 认为长期增长的可视性和持久性将继续提高
** 21家券商中有11家将该股评为 "买入 "或更高评级，10家为 "持有"；其PT中值为65美元--数据由LSEG编制
** 截至上次收盘，该股今年累计下跌约 13
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.